TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive New Funding Mechanisms – Cooperative Agreement, Consortium Grant – Proposed For Clinical Groups April 6, 1979
TCL Archive Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University. March 11, 2005